PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1877471
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1877471
Interventional Ultrasound Market size was valued at US$ 2,345.89 Million in 2024, expanding at a CAGR of 6.1% from 2025 to 2032.
Interventional ultrasound is transforming modern healthcare by enabling real-time imaging to guide minimally invasive diagnostic and therapeutic procedures. The rising preference for minimally invasive surgeries, which shorten recovery times and improve patient outcomes, is fueling its rapid adoption. A key opportunity is the integration of AI and advanced imaging software to improve precision. The field is also witnessing a strong trend toward portable and point-of-care ultrasound devices. However, progress is constrained by a shortage of professionals with expertise in advanced interventional ultrasound techniques.
Interventional Ultrasound Market- Market Dynamics
Growing prevalence of cancer, cardiovascular disease (CVD), and chronic liver disease
The global rise in cancer, cardiovascular disease (CVD), and chronic liver disease is a key factor driving growth in interventional ultrasound procedures such as biopsies and ablations. According to the World Cancer Research Fund, there were 866,136 new cases of liver cancer in 2022. Additionally, China, the U.S., and Japan had the highest number of liver cancer cases in 2022. Similarly, cardiovascular diseases remain one of the leading global causes of mortality, necessitating minimally invasive diagnostic and therapeutic interventions that benefit from real-time imaging guidance offered by interventional ultrasound. The increasing incidence of these chronic diseases has led to greater demand for accurate, less invasive procedures to diagnose and treat tumors and lesions, driving biopsy and ablation volumes upward. Moreover, interventional ultrasound's ability to provide precise, real-time visualization during procedures makes it a critical tool in managing these diseases, enabling targeted biopsies and effective ablations with minimal patient risk. As the burden of cancer, CVD, and chronic liver disease continues to rise globally, the resulting growth in biopsy and ablation procedures directly fuels the expanding adoption and advancement of interventional ultrasound technology.
The Global Interventional Ultrasound Market is segmented on the basis of Product Type, Application, End User, and Region.
The market is divided into two categories based on Product Type: Diagnostic Ultrasound Systems and Therapeutic Ultrasound Systems. Diagnostic ultrasound systems use high-frequency sound waves to create images of internal body structures for diagnosis. Therapeutic ultrasound systems use sound waves to treat conditions by promoting healing and pain relief.
The market is divided into six categories based on Application: Cardiology, Oncology, Urology, Musculoskeletal Intervention, Obstetrics and Gynecology, and Others. Interventional ultrasound is widely used in cardiology for heart imaging, oncology for tumor detection and treatment, urology for kidney and bladder interventions, musculoskeletal for joint and muscle diagnosis, and obstetrics and gynecology for fetal monitoring and reproductive health, among other applications.
Interventional Ultrasound Market- Geographical Insights
The interventional ultrasound market shows significant geographical variation, with Asia Pacific (APAC) emerging as the fastest-growing region. Rapid healthcare infrastructure development in countries like China, India, Japan, and South Korea, coupled with growing demand for minimally invasive procedures, fuels this expansion. Technological advancements, including portable devices, contrast-enhanced ultrasound, elastography, and AI integration, further accelerate market adoption. However, challenges such as operator dependency, reimbursement variability, and affordability issues in low- and middle-income countries persist. North America holds the largest market share globally due to its mature healthcare system, significant investments in R&D, and well-established reimbursement frameworks. Europe also demonstrates steady growth, supported by increasing awareness and investment in interventional ultrasound technologies. Countries like Germany, the UK, and Italy contribute to this growth due to their advanced healthcare infrastructures and ongoing innovation efforts. In Latin America, the Middle East & Africa (MEA), market growth is fueled by increasing healthcare expenditure, rising awareness of minimally invasive procedures, and expanding medical device infrastructure.
Interventional Ultrasound Market- Country Insights
The U.S. interventional ultrasound market shows significant growth, owing to rising chronic disease prevalence, including cancer and cardiovascular conditions. The U.S. market benefits from advanced healthcare infrastructure, high patient preference for minimally invasive procedures, and rapid adoption of technological innovations like AI integration and portable ultrasound devices. Medicare reimbursement policies supporting outpatient imaging and increased awareness of minimally invasive options further propel market expansion. The rising demand for point-of-care ultrasound in cardiology, oncology, and musculoskeletal interventions also contributes to market growth.
The competitive landscape of the interventional ultrasound market is dominated by several key global players leveraging technological innovation and strategic collaborations to strengthen their positions. The market leaders focus on developing advanced imaging technologies, such as AI-powered automation, contrast-enhanced ultrasonography, elastography, and portable ultrasound devices, driving market growth. Their strategies include extensive R&D investments, partnerships with medical institutions, and expanding clinical applications across cardiology, oncology, musculoskeletal, and other fields. For instance, in January 2025, GE HealthCare received FDA 510(k) clearance for its enhanced Voluson Expert Series ultrasound systems, which include the Voluson Expert 22, 20, and 18 models. These systems combine high-resolution imaging, advanced artificial intelligence features, and an ergonomic design to improve workflow efficiency and diagnostic accuracy in women's healthcare, especially for high-risk pregnancies. As the interventional ultrasound market continues to expand globally, competition intensifies with firms focusing on technological advancements, strategic acquisitions, and expanded clinical indications to capture market share and meet the rising demand for minimally invasive, image-guided interventions.
In February 2023, FUJIFILM Holdings Corporation introduced the Arietta 850 DeepInsight ultrasound system, a premium diagnostic platform that delivers outstanding image quality through advanced AI-powered technologies such as eFocusing PLUS, which ensures homogeneous high-resolution imaging from near to far fields.
In November 2023, Canon Medical Systems unveiled its flagship CT scanner, the Aquilion ONE / INSIGHT Edition, featuring advanced AI-enhanced imaging capabilities. The system incorporates Deep Learning Reconstruction technology called the Precise IQ Engine (PIQE), delivering ultra-high-resolution 1024 matrix CT images with exceptional clarity and low noise, without increasing radiation dose